These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3676056)

  • 1. Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis.
    Kenna JG; Neuberger J; Williams R
    Br J Anaesth; 1987 Oct; 59(10):1286-90. PubMed ID: 3676056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halothane hepatitis in children.
    Kenna JG; Neuberger J; Mieli-Vergani G; Mowat AP; Williams R
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1209-11. PubMed ID: 3109584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis.
    Bird GL; Williams R
    J Hepatol; 1989 Nov; 9(3):366-73. PubMed ID: 2607125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.
    Kenna JG; Neuberger J; Williams R
    J Pharmacol Exp Ther; 1987 Aug; 242(2):733-40. PubMed ID: 3302210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.
    Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S
    Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis.
    Kenna JG; Neuberger J; Williams R
    Hepatology; 1988; 8(6):1635-41. PubMed ID: 3192177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.
    Knight TL; Scatchard KM; Van Pelt FN; Kenna JG
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1325-33. PubMed ID: 7932186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia.
    Neuberger J; Gimson AE; Davis M; Williams R
    Br J Anaesth; 1983 Jan; 55(1):15-9. PubMed ID: 6821618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
    Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
    Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.
    Kitteringham NR; Kenna JG; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.
    Vergani D; Mieli-Vergani G; Alberti A; Neuberger J; Eddleston AL; Davis M; Williams R
    N Engl J Med; 1980 Jul; 303(2):66-71. PubMed ID: 6991940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens.
    Kenna JG; Neuberger J; Williams R
    J Immunol Methods; 1984 Dec; 75(1):3-14. PubMed ID: 6392423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to induce hepatic pathology in animals sensitized to a halothane metabolite and subsequently challenged with halothane.
    Reves JG; McCracken LE
    Anesth Analg; 1976; 55(2):235-42. PubMed ID: 943984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane hepatitis.
    Neuberger J; Williams R
    Dig Dis; 1988; 6(1):52-64. PubMed ID: 3349642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte cytotoxicity to halothane altered hepatocytes in patients with severe hepatic necrosis following halothane anaesthesia.
    Mieli-Vergani G; Vergani D; Tredger JM; Eddleston AL; Davis M; Williams R
    J Clin Lab Immunol; 1980 Jul; 4(1):49-51. PubMed ID: 7463474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic damage after exposure to halothane in medical personnel.
    Neuberger J; Vergani D; Mieli-Vergani G; Davis M; Williams R
    Br J Anaesth; 1981 Nov; 53(11):1173-7. PubMed ID: 7326163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia.
    Vergani D; Tsantoulas D; Eddleston AL; Davis M; Williams R
    Lancet; 1978 Oct; 2(8094):801-3. PubMed ID: 81359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for antibodies associated with halothane hepatitis.
    Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
    Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane hepatitis in a young child.
    Lewis RB; Blair M
    Br J Anaesth; 1982 Mar; 54(3):349-54. PubMed ID: 7066130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA A and B locus antigens in patients with unexplained hepatitis following halothane anaesthesia.
    Eade OE; Grice D; Krawitt EL; Trowell J; Albertini R; Festenstein H; Wright R
    Tissue Antigens; 1981; 17(4):428-32. PubMed ID: 7330846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.